Division News

Researchers identify genetic drivers of most common form of lymphoma

An international research effort led by Duke Cancer Institute scientists has been working to better understand the genetic underpinnings of diffuse large B cell lymphoma and how those genes might play a role in patients’ responses to therapies. The findings were published this week in the journal Cell.

Harnessing genetics to disrupt blood cancers

To better understand blood cancers, Sandeep Davé, MD, MBA, MS, hunts down variation in the DNA sequences important to those cancers. One international project he launched is deploying comparative genetics to better classify the more than 100 blood cancers.

But the research never stops there.

Funding opp: Duke-UNC Immunotherapy Training Grant

The Duke-UNC Immunotherapy Training Grant (DUNC-IMTG) is a NCI-funded T32 training program at the University of North Carolina at Chapel Hill and Duke University that trains postdoctoral fellows in pre-clinical and/or clinical research focusing on tumor immunotherapy and/or stem cell transplantation immunology. Applications for 2017-18 are due at 5 p.m. on Aug. 11, 2017.

Congratulations to the Department of Medicine's Duke Health Scholars and Fellows

Fourteen faculty from the Department of Medicine were chosen as Duke Health Scholars and Duke Health Fellows. This inaugural program was created with a transfer of funds from the Duke University Health System. Its aim is to support the research efforts and enhance the academic success of early to mid-career clinician-scientists in School of Medicine clinical departments.